EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Celastrol Treatment Ameliorated Acute Ischemic Stroke‐Induced Brain Injury by Microglial Injury Inhibition and Nrf2/HO‐1 Pathway Activations

Fanfan Cao, Ying Wang, Yuting Song, Fengxia Xu, Qiuhua Xie, Mei Jiang iD, Xinghui Liu iD, Denghai Zhang iD, Limin Xu iD

BioMed Research International · 2023

DOI: 10.1155/2023/1076522 ↗

Kurz gefasst

Fachartikel in der Zeitschrift BioMed Research International, 2023. Verfasst von Fanfan Cao und 8 weiteren Autor:innen. Beteiligte Einrichtung: Sino-French Cooperative Central Lab, Gongli Hospital of Shanghai Pudong New Area, No. 207, Juye Rd., Pudong New District, Shanghai 200135, China. Hauptthemen laut MEDLINE: Ischemic Stroke, Brain Injuries, Reperfusion Injury. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Disciplines Group Construction Project of Pudong Health Bureau of Shanghai, Discipline Leader Project of Pudong Health Bureau of Shanghai, Pudong New Area Science and Technology Development Foundation Project of Pudong New Area Science and Technology Commission.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Stroke is the third main reason of mortality, which is the leading reason for adult disability in the globe. Poststroke inflammation is well known to cause acute ischemic stroke‐ (AIS‐) induced brain injury (BI) exacerbation. Celastrol (CL) has exhibited anti‐inflammatory activities in various inflammatory traits though underlying mechanisms remain unknown. So, the present investigation is aimed at studying CL protective mechanism against AIS‐induced BI.

Methods

A mouse model regarding middle cerebral artery occlusion and an oxygen‐glucose deprivation (OGD) cell model with or not CL treatment were constructed to study CL protective effects. NF‐E2‐related factor 2 (Nrf2) was then silenced in BV2 microglia cells (BV2) to study Nrf2 role regarding CL‐mediated neuroprotection.

Results

The results showed that CL treatment suppressed AIS‐induced BI by inhibiting NLRP3/caspase‐1 pathway activations and induction of apoptosis and pyroptosis in vivo and in vitro . NLRP3/caspase‐1 pathway blocking activation suppressed OGD‐induced cell pyroptosis and apoptosis. Also, CL treatment reversed OGD‐induced microglial injury by promoting Nrf2/heme oxygenase‐1 (HO‐1) pathway activations. Nrf2 downregulation reversed CL protective effects against OGD‐induced microglial injury, pyroptosis, and apoptosis.

Conclusion

The findings advise that CL treatment ameliorated AIS‐induced BI by inhibiting microglial injury and activating the Nrf2/HO‐1 pathway.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Ischemic StrokeBrain InjuriesReperfusion InjuryMiceAnimalsHeme Oxygenase-1MicrogliaNF-E2-Related Factor 2Oxidative StressNLR Family, Pyrin Domain-Containing 3 ProteinSignal TransductionOxygenCaspasesPentacyclic Triterpenes

Substanzen

Heme Oxygenase-1NF-E2-Related Factor 2NLR Family, Pyrin Domain-Containing 3 ProteinOxygenCaspasescelastrolPentacyclic Triterpenes

Autor:innen und Institutionen

  • Sino-French Cooperative Central Lab, Gongli Hospital of Shanghai Pudong New Area, No. 207, Juye Rd., Pudong New District, Shanghai 200135, China.
  • Ningxia Medical University, Ningxia 750000, China.
  • Department of Clinical Laboratory, Gongli Hospital of Shanghai Pudong New Area, 207 Juye Road, Pudong New Area, Shanghai 200135, China.
  • Department of Neurology, Gongli Hospital of Shanghai Pudong New Area, Shanghai 200135, China.

ORCID-Profile: Mei Jiang, Xinghui Liu, Denghai Zhang, Limin Xu

Förderung

  • Disciplines Group Construction Project of Pudong Health Bureau of Shanghai
  • Discipline Leader Project of Pudong Health Bureau of Shanghai
  • Pudong New Area Science and Technology Development Foundation Project of Pudong New Area Science and Technology Commission

Zitieren

APA

Cao, F., Wang, Y., Song, Y., Xu, F., Xie, Q., Jiang, M., Liu, X., Zhang, D., & Xu, L. (2023). Celastrol Treatment Ameliorated Acute Ischemic Stroke‐Induced Brain Injury by Microglial Injury Inhibition and Nrf2/HO‐1 Pathway Activations. BioMed Research International. https://doi.org/10.1155/2023/1076522

Vancouver

Cao F, Wang Y, Song Y, Xu F, Xie Q, Jiang M, et al. Celastrol Treatment Ameliorated Acute Ischemic Stroke‐Induced Brain Injury by Microglial Injury Inhibition and Nrf2/HO‐1 Pathway Activations. BioMed Research International. 2023. doi:10.1155/2023/1076522

BibTeX
@article{Cao2023,
  author = {Cao, Fanfan and Wang, Ying and Song, Yuting and Xu, Fengxia and Xie, Qiuhua and Jiang, Mei and Liu, Xinghui and Zhang, Denghai and Xu, Limin},
  title = {Celastrol Treatment Ameliorated Acute Ischemic Stroke‐Induced Brain Injury by Microglial Injury Inhibition and Nrf2/HO‐1 Pathway Activations},
  journal = {BioMed Research International},
  year = {2023},
  doi = {10.1155/2023/1076522}
}
Kostenlos starten →